A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
Clinical trial NCT03899259 · COMPLETED
Trial details
- NCT number
- NCT03899259
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-08
- Primary completion
- 2021-01-24
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.